PL414469A1 - Method for detecting increased kidney cancer incidence risk and applications of the genotype variants of GRHL1 and/or GRHL2 and/or GRHL3 genes - Google Patents

Method for detecting increased kidney cancer incidence risk and applications of the genotype variants of GRHL1 and/or GRHL2 and/or GRHL3 genes

Info

Publication number
PL414469A1
PL414469A1 PL414469A PL41446915A PL414469A1 PL 414469 A1 PL414469 A1 PL 414469A1 PL 414469 A PL414469 A PL 414469A PL 41446915 A PL41446915 A PL 41446915A PL 414469 A1 PL414469 A1 PL 414469A1
Authority
PL
Poland
Prior art keywords
grhl3
grhl1
grhl2
genes
kidney cancer
Prior art date
Application number
PL414469A
Other languages
Polish (pl)
Other versions
PL234915B1 (en
Inventor
Magdalena Pawlak
Agnieszka Kikulska
Tomasz Wilanowski
Bartosz Wilczyński
Joanna Wesoły
Original Assignee
Instytut Biologii Doświadczalnej Im. M. Nenckiego Polskiej Akademii Nauk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Biologii Doświadczalnej Im. M. Nenckiego Polskiej Akademii Nauk filed Critical Instytut Biologii Doświadczalnej Im. M. Nenckiego Polskiej Akademii Nauk
Priority to PL414469A priority Critical patent/PL234915B1/en
Priority to PCT/IB2015/059225 priority patent/WO2017068402A1/en
Publication of PL414469A1 publication Critical patent/PL414469A1/en
Publication of PL234915B1 publication Critical patent/PL234915B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Zgłoszenie dotyczy metod identyfikacji polimorfizmów pojedynczego nukleotydu (ang. single nucleotide polymorphism - SNP) w genach GRHL1 i/lub GRHL2 i/lub GRHL3 oraz wykorzystania tych polimorfizmów jako markerów do określenia zwiększonej podatności pacjentów na zachorowanie na raka nerki.The application concerns methods for the identification of single nucleotide polymorphism (SNP) in the GRHL1 and / or GRHL2 and / or GRHL3 genes and the use of these polymorphisms as markers to determine the increased susceptibility of patients to kidney cancer.

PL414469A 2015-10-23 2015-10-23 Method for detecting increased kidney cancer incidence risk and applications of the genotype variants of GRHL1 and/or GRHL2 and/or GRHL3 genes PL234915B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL414469A PL234915B1 (en) 2015-10-23 2015-10-23 Method for detecting increased kidney cancer incidence risk and applications of the genotype variants of GRHL1 and/or GRHL2 and/or GRHL3 genes
PCT/IB2015/059225 WO2017068402A1 (en) 2015-10-23 2015-11-30 A method for detecting an increased risk of kidney cancer and the use of genotype variants of genes grhl1 and / or grhl2 and / or grhl3

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL414469A PL234915B1 (en) 2015-10-23 2015-10-23 Method for detecting increased kidney cancer incidence risk and applications of the genotype variants of GRHL1 and/or GRHL2 and/or GRHL3 genes

Publications (2)

Publication Number Publication Date
PL414469A1 true PL414469A1 (en) 2017-04-24
PL234915B1 PL234915B1 (en) 2020-05-18

Family

ID=55359545

Family Applications (1)

Application Number Title Priority Date Filing Date
PL414469A PL234915B1 (en) 2015-10-23 2015-10-23 Method for detecting increased kidney cancer incidence risk and applications of the genotype variants of GRHL1 and/or GRHL2 and/or GRHL3 genes

Country Status (2)

Country Link
PL (1) PL234915B1 (en)
WO (1) WO2017068402A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050130193A1 (en) * 2003-09-10 2005-06-16 Luxon Bruce A. Methods for detecting, diagnosing and treating human renal cell carcinoma
WO2013029116A1 (en) 2011-08-31 2013-03-07 Monash University Method for predicting treatment responsiveness
US10000816B2 (en) * 2013-12-19 2018-06-19 Instytut Biologii Doswiadczalnej Im. M. Nenckiego Polskiej Akademii Nauk Method for detecting an increased risk of developing skin cancer and a use of a genotype variant of the GRHL3 gene

Also Published As

Publication number Publication date
PL234915B1 (en) 2020-05-18
WO2017068402A1 (en) 2017-04-27

Similar Documents

Publication Publication Date Title
MX2022007933A (en) Polymethine compounds and their use as fluorescent labels.
WO2015058008A3 (en) Enhanced nucleic acid identification and detection
GB2526736A (en) Methods, compositions, and kits for nucleic acid analysis
MX2022012384A (en) Compositions and methods for screening mutations in thyroid cancer.
MX2017010836A (en) Biomarker panel for the detection of cancer.
BR112015002626A2 (en) methods for tumor metastasis prevention, cancer treatment and prognosis, and identification of agents that are putative metastasis inhibitors
SG10201804519RA (en) Methods and systems for detecting genetic variants
EP3862439A3 (en) Liver cancer detection kit or device, and detection method
EA201400117A1 (en) METHODS AND NUCLEIC ACIDS FOR DETERMINATION OF THE PREDICTION IN CANCER PATIENTS
WO2014116729A3 (en) Haplotying of hla loci with ultra-deep shotgun sequencing
SA518392005B1 (en) Deep sequencing profiling of tumors
BR112015008621A2 (en) METHODS AND DIAGNOSTIC AND / OR PROGNOSTIC KIT IN VITRO NUCLEIC ACID MICRO-ASSEMBLY.
MX2017004927A (en) Methods of genomic evaluation in livestock.
FR3031641B1 (en) METHOD OF IDENTIFYING AN ENTITY
MX2022013471A (en) Nucleic acid detection and quantification method and compositions.
FR3043811B1 (en) METHOD OF IDENTIFYING AN ENTITY
MX2016001439A (en) Compositions and methods for identifying a risk of cancer in a subject.
BR112017003559A2 (en) methods for rapid and sensitive detection of target site mutations
MX2019007894A (en) Compositions and methods for detecting circulating tumor dna.
DK3377654T3 (en) SYSTEMS AND METHODS FOR IDENTIFYING AND DISTINGUISHING BETWEEN GENETIC SPECIMENS
MX2016002529A (en) Risk markers for cardiovascular disease in patients with chronic kidney disease.
GB201302900D0 (en) Nucleic acid marker molecules for identifying and detecting cross contaminationof nucleic acid samples
EP3724882C0 (en) Methods for detecting variants in next-generation sequencing genomic data
MY182547A (en) Polymerase chain reaction detection system
PL414469A1 (en) Method for detecting increased kidney cancer incidence risk and applications of the genotype variants of GRHL1 and/or GRHL2 and/or GRHL3 genes